Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Inflammatory Breast Neoplasms × Razoxane × Clear all

Sponsor

Conditions

Sarcoma 2 Sarcoma, Synovial 1 Rhabdoid Tumor 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 PRETEXT I Hepatoblastoma 1 Osteosarcoma 1 Neurofibrosarcoma 1 Neuroblastoma 1 Lymphoma, Large-Cell, Anaplastic 1 Localized Extraskeletal Ewing Sarcoma 1 Liposarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1 Ganglioneuroblastoma 1 Fibrosarcoma 1 Dermatofibrosarcoma 1 Central Nervous System Neoplasms 1

Interventions

Cyclophosphamide 13 Doxorubicin 9 Trastuzumab 8 Taxes 7 Paclitaxel 7 Docetaxel 5 Carboplatin 5 Albumin-Bound Paclitaxel 5 Radiotherapy 4 Epirubicin 4 pertuzumab 3 pembrolizumab 3 Melphalan 3 130-nm albumin-bound paclitaxel 3 eribulin 2 Thiotepa 2 Tamoxifen 2 Peripheral Blood Stem Cell Transplantation 2 Lapatinib 2 Fluorouracil 2 Filgrastim 2 Bevacizumab 2 2C4 antibody 2 trastuzumab biosimilar HLX02 1 talimogene laherparepvec 1 sargramostim 1 ruxolitinib 1 romidepsin 1 pegfilgrastim 1 pazopanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡